(Q44001363)

28 November 2017

Reversible posterior leukoencephalopathy secondary to indinavir-induced hypertensive crisis: a case report (English)

1 reference

28 November 2017

1 reference

1 reference

Vicente Giner

1

1 reference

28 November 2017

Conrado Fernández

2

1 reference

28 November 2017

Maria José Esteban

3

1 reference

28 November 2017

Maria José Galindo

4

1 reference

28 November 2017

Maria José Forner

5

1 reference

28 November 2017

José Guix

6

1 reference

28 November 2017

Josep Redón

7

1 reference

28 November 2017

1 May 2002

1 reference

Journal of Clinical Hypertension

28 November 2017

1 reference

28 November 2017

15

1 reference

28 November 2017

5

1 reference

28 November 2017

465-467

1 reference

A reversible posterior leukoencephalopathy syndrome

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902264-1

7 January 2021

Toxic leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902264-1

7 January 2021

Occipital lobe seizures as the major clinical manifestation of reversible posterior leukoencephalopathy syndrome: magnetic resonance imaging findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902264-1

7 January 2021

Progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902264-1

7 January 2021

Indinavir and systemic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902264-1

7 January 2021

Hypertensive crisis secondary to phenylpropanolamine interacting with triple-drug therapy for HIV prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902264-1

7 January 2021

Severe hypertension and renal atrophy associated with indinavir

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2802%2902264-1

7 January 2021

10.1016/S0895-7061(02)02264-1

Identifiers

DOI

1 reference

28 November 2017

1 reference